Table 5 Pharmacokinetics of AZD3199
From: Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study
Variable | Dose group | n | G meana | CVb |
|---|---|---|---|---|
Cmax (nmol/L) | 200 μg | 53 | 1.136 | 118.5 |
400 μg | 64 | 1.882 | 190.1 | |
800 μg | 59 | 4.011 | 107.0 | |
AUC0-24 (nmol*h/L) | 200 μg | 53 | 4.91 | 99.5 |
400 μg | 64 | 8.75 | 138.7 | |
800 μg | 59 | 14.85 | 107.1 |